The global medical disposal products market was over USD 521.91 Billion in 2025 and may reach USD 1038.21 Billion by 2031 (CAGR 12.46%).
The market is driven by various factors such as rising incidence of Hospital Acquired Infections (HAIs), increasing number of surgical procedures, growing geriatric population across the globe, and increasing prevalence of chronic diseases leading to longer hospital admission. In high-income countries, approximately seven out of every 100 patients, and in low- and middle-income countries, about 15 out of every 100 patients, were reported to be at risk of contracting at least one HAI during their hospitalization. The discernible rise in HAI prevalence attributed to inadequate sanitation practices and preventive measures emerges as a pivotal factor anticipated to drive market growth throughout the forecast period. Additionally, novel product launch by industry key players boosts the industry growth. Furthermore, increasing healthcare expenditure, particularly in developed countries, has been a significant driver of the market. With a growing aging population, there is increasing demand for healthcare services, including surgical procedures, diagnostic tests, and long-term care. This demographic shift has led to a surge in the use of medical disposables such as syringes, gloves, catheters, and wound care products. The need for these disposables to maintain hygiene standards and prevent cross-contamination in healthcare settings is contributing to the market growth. Increasing the geriatric patient population globally would boost the market growth for medical disposables in near future. According to World Health Organization (WHO) reports of 2022, approximately 80% of the elderly population is projected to be residing in low or middle-income nations by 2050. The demographic landscape was further characterized by an anticipated surge in the number of individuals aged 80 years or older, reaching an estimated 426 million globally by 2050. According to the research report "Global Medical Disposal Products Market Outlook, 2031," published by Bonafide Research, the Global Medical Disposal Products market was valued at more than USD 521.91 Billion in 2025, and expected to reach a market size of more than USD 1038.21 Billion by 2031 with the CAGR of 12.46% from 2026-2031. Furthermore, growing manufacturers' initiatives to expand the product portfolio with novel product launches are further anticipated to influence the market for medical disposables over the forecast period. For instance, in January 2024, Inspira-Technologies OXY B.H.N. LTD. proposed a plan involving development and impending launch of a single-use disposable blood oxygenation kit. This kit, currently in the developmental phase, is specifically designed for seamless integration with the medical device series- INSPIRA ART. Notably, the kit is engineered to be compatible with various life support machinery, strategically positioning the company to tap into and exploit the growing market demand for disposable perfusion systems. This strategic maneuver underscores the organization's dedication to innovation and market expansion within the dynamic landscape of medical device sector. Key strategies implemented by players in the market are new product launches, expansion, acquisitions, partnerships, and other strategies. In March 2023, IceCure Medical Ltd. reported approval by the National Medical Products Administration (NMPA) of China for the commercial utilization of the company's IceSense3 disposable cryoprobes. These cryoprobes are intended for use in conjunction with the IceSense3 console, which had received prior approval from the NMPA. This regulatory milestone signified a significant advancement for IceCure Medical Ltd. in expanding the commercialization of its cryoablation technology in the Chinese market. Technological advancements in materials science, such as development of biodegradable polymers, antimicrobial coatings, and materials exhibiting heightened strength and flexibility, have significantly elevated the operational efficacy of disposable medical products. With the increasing awareness regarding environmental sustainability, there has been a notable trend favoring eco-friendly disposable products.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Product Type | Wound Management Products: | |
| Injection & Infusion Products: | ||
| Surgical Products | ||
| Diagnostic & Testing Products | ||
| Incontinence & Hygiene Products | ||
| Respiratory Care Products | ||
| Dialysis Products | ||
| Other Sterile Packaging & Disposables | ||
| By Material Type | Plastics & Polymers | |
| Non-woven Materials | ||
| Rubber & Latex | ||
| Metals | ||
| Others | ||
| By End-User | Hospitals | |
| Clinics & Ambulatory Surgical Centers (ASCs) | ||
| Diagnostic Laboratories & Blood Banks | ||
| Home Healthcare Settings | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Injection and infusion products generate the highest volume of frequent single use hazardous waste across all healthcare settings which directly drive their dominance in the global medical disposal market. The products include syringes needles intravenous sets cannulas and infusion bags which are essential for medication delivery vaccinations blood transfusions anesthesia chemotherapy and fluid management making them indispensable in hospitals clinics ambulatory care centers home healthcare and emergency services. Unlike many other medical products injection and infusion items are almost always single use to prevent cross contamination and infection transmission which significantly increases disposal volume on a daily basis. Each procedure whether minor or critical results in sharps waste and potentially infectious plastic waste that is classified as hazardous and requires specialized segregation collection transportation and treatment. The high frequency of injections worldwide driven by rising chronic diseases such as diabetes cancer cardiovascular disorders and autoimmune conditions further amplifies waste generation from this segment. In addition global immunization programs routine vaccinations pandemic response initiatives and mass drug administration campaigns rely heavily on injection based delivery which leads to sudden surges in disposal demand especially in public healthcare systems. From a regulatory perspective injection and infusion waste is subject to some of the strictest medical waste regulations because sharps pose direct risks of needle stick injuries and bloodborne infections such as hepatitis and HIV. As a result healthcare providers are mandated to use approved disposal containers and licensed waste management services which increases the commercial value of this waste stream within the medical disposal market. Plastics and polymers dominate the medical disposal market because the vast majority of medical products and single use items are made from plastic materials which generate the highest volume of disposable medical waste. The shift from reusable metal or glass instruments to single use plastic alternatives has been driven by the need to reduce cross contamination and infection risks which has significantly increased the volume of plastic waste generated in healthcare facilities. Unlike other materials medical plastics are lightweight durable and resistant to chemical and biological interactions which makes them ideal for sterilization and one time use applications but also means they are non-biodegradable and require specialized disposal solutions. Hospitals clinics laboratories and home healthcare settings generate continuous streams of plastic waste on a daily basis from routine procedures injections blood collection surgery diagnostic testing and patient care products which makes plastics the most common and highest volume material in medical waste streams. In addition the growing use of disposable personal protective equipment such as masks gowns face shields and gloves during pandemics and for infection control has further amplified plastic waste generation. The regulatory environment also contributes to this dominance because biomedical waste guidelines classify most used plastics as hazardous waste when contaminated with blood or other body fluids requiring collection in color coded containers secure transport and treatment by licensed medical disposal companies. Recycling options for contaminated medical plastics are limited due to infection risks and the presence of chemical residues which increases reliance on disposal technologies such as incineration autoclaving microwaving and chemical treatment thereby expanding the commercial scope of the market. Hospitals are the largest end-user in the global medical disposal market because they generate the highest volume of diverse and continuous medical waste requiring specialized handling and treatment. Hospitals manage large numbers of patients daily, including those in emergency care, surgery, intensive care, oncology, dialysis, and maternity services, all of which produce substantial amounts of hazardous and non-hazardous waste. The waste streams include sharps, contaminated plastics, used linens, pharmaceutical residues, blood and body fluids, chemical reagents, and laboratory disposables, making the volume and variety of waste from hospitals significantly higher than other healthcare facilities such as clinics, diagnostic centers, or home care providers. Regulatory compliance is a critical factor that reinforces the hospital segment's dominance, as hospitals are required to adhere to strict biomedical waste management guidelines, which mandate segregation, collection, transportation, treatment, and disposal of medical waste according to type and hazard level. This drives continuous demand for professional waste disposal services, specialized containers, autoclaves, incinerators, and monitoring systems, ensuring that hospitals remain primary consumers of medical disposal solutions. Hospitals also tend to adopt the latest waste management technologies due to safety concerns, infection control priorities, and large operational budgets, further increasing their market share in the medical disposal industry. The increasing prevalence of chronic diseases, aging populations, and the expansion of healthcare infrastructure in emerging economies contribute to higher patient volumes and longer hospital stays, generating additional medical waste and reinforcing the centrality of hospitals in the market.
to Download this information in a PDF
North America leads the global medical disposal market because of its highly developed healthcare infrastructure, strict regulatory environment, and high medical waste generation per capita. The region has a dense network of hospitals, clinics, diagnostic laboratories, outpatient centers, and long-term care facilities that generate diverse waste streams, including infectious, hazardous, sharps, pharmaceutical, and chemical waste. The United States, in particular, produces one of the highest amounts of medical waste per capita globally, driven by a high number of surgical procedures, diagnostic tests, and widespread use of disposable products such as syringes, infusion sets, gloves, masks, and personal protective equipment. This consistent high volume of waste creates a continuous and substantial demand for professional medical disposal services, advanced treatment technologies such as autoclaving, incineration, and chemical disinfection, as well as safe transportation and handling systems. Regulatory requirements play a crucial role in maintaining North America’s market leadership, as agencies such as the Environmental Protection Agency, Occupational Safety and Health Administration, and state-level health departments strictly enforce biomedical waste management rules, making compliance a priority for all healthcare providers. The strict enforcement ensures that hospitals and other medical facilities adopt approved disposal methods, contract licensed waste management companies, and invests in safe waste segregation and treatment technologies, which drives growth for the medical disposal market. Furthermore, technological innovation is widespread in the region, with digital tracking systems, smart containers, IoT-enabled waste monitoring, and automation being increasingly implemented to optimize efficiency, ensure compliance, and minimize environmental risks.
to Download this information in a PDF
• July 2025: Johnson & Johnson launched a disposable multifocal toric contact lens, ACUVUE OASYS MAX 1-Day MULTIFOCAL. The lens is useful for a person suffering from presbyopia and astigmatism. The lens offers stable, crisp, and clear vision across all distances. • July 2025: Medtronic extended its long-term partnership with Philips to bundle Medtronic-enabled consumables—including disposable pulse oximetry sensors, capnography lines, BIS brain monitoring electrodes, ECG, and NIBP supplies—with Philips’ patient monitoring systems. • April 2025: Intco Medical launched new Syntex synthetic disposable latex gloves. The gloves are fully compliant with EU CE and FDA standards. Syntex gloves are available for use in various industries like industrial protection, healthcare, and food processing. The gloves have strong chemical & puncture resistance and provide high elasticity. • December 2024: ConTIPI Medical launched the ProVate disposable device for pelvic organ prolapse in the United States. The patients can easily use the device at home, and it is available in six sizes. The device can be used up to 7 days and is available for physicians. • November 2024: Cardinal Health acquired Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-home Solutions growth strategy. • January 2024: BIOCORP officially disclosed the attainment of 510(K) clearance from the U.S. FDA for the commercialization of SoloSmart, Sanofi's intelligent medical device designed to facilitate connectivity with SoloStar insulin pens. • September 2023: Medtronic recently received CE Mark approval for its innovative Simplera continuous glucose monitor (CGM). This device is an integrated disposable device offering a simplified two-step insertion process. It has a no-fingerstick sensor, eliminating the need for overtape. The advanced CGM seamlessly connects with the InPen smart insulin pen. • May 2023: Indegene announced of expanding its partnership with ConTIPI Medical, a company specializing in non-invasive and disposable solutions for women experiencing diverse pelvic floor disorders. This extended partnership aims to introduce a novel device to the market. • March 2023: IceCure Medical Ltd. disclosed that China's National Medical Products Administration (NMPA) approved commercializing the company's IceSense3 disposable cryoprobes. These cryoprobes are intended for use with IceCure Medical's previously sanctioned IceSense3 console, further solidifying regulatory clearance from the NMPA for the complete system.

We are friendly and approachable, give us a call.